He may not have been breathing fire and brimstone, but industry collaboration advocate and director of the Division of Translational Medicine at Brigham and Women’s Hospital, Boston; and Harvard Medical School Professor Thomas Stossel, MD, gave what amounted to a secular sermon on the benefits of commercial investment in healthcare at the 15th Annual Global Alliance for Medical Education Meeting in June. His central question: “Is commercialization a good thing or not (with ‘good’ being an ...

Register for Complete Access (Valid Email Required)

By registering on MeetingsNet now, you'll not only unlock the Thomas Stossel, MD, on Commercial Support: Sin or Salvation?, you'll also gain access to exclusive premium content.

Already registered? here.